Nutritional priorities to support GLP1 therapy for obesity: a Joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society
In a retrospective cohort study, supplemented with a nested case-control study, using two US administrative databases, Liang et al (2019) found a non-significant trend toward increased risk of thyroid cancer with exenatide (OR 1.46, 95% CI 0.982.19) (9)
I love how I look now but most importantly I love the mental freedom I have gained from not always focusing on food, dieting, or feeling bad about myself for not accomplishing goals
Retatrutide is not yet licensed in the UK by the MHRA or EMA, and it is important to clarify that doses are measured in milligrams (mg), not 'units' as used for insulin
Her doctor fought to keep her on the GLP-1 agonist, the category that includes weight loss and Type 2 diabetes drugs Ozempic, Wegovy, Mounjaro and Zepbound
GLP-1 medications such as Ozempic and Wegovy have become increasingly common for weight management and metabolic health